Cardiotoxicity after vemurafenib administration

Hellenic J Cardiol. 2019 Jul-Aug;60(4):256-257. doi: 10.1016/j.hjc.2018.09.003. Epub 2018 Oct 4.
No abstract available

Keywords: Drug cardiotoxicity; Targeted drug therapy; Vemurafenib.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Bundle-Branch Block / chemically induced
  • Bundle-Branch Block / physiopathology
  • Cardiotoxicity / epidemiology*
  • Cardiotoxicity / physiopathology
  • Echocardiography / methods
  • Electrocardiography / methods
  • Female
  • Humans
  • Magnetic Resonance Imaging / methods
  • Melanoma / complications*
  • Melanoma / drug therapy
  • Melanoma / genetics
  • Melanoma / secondary
  • Middle Aged
  • Molecular Targeted Therapy / adverse effects
  • Molecular Targeted Therapy / methods
  • Mutation
  • Natriuretic Peptide, Brain / blood
  • Neoplasm Metastasis / pathology
  • Protein Kinase Inhibitors / administration & dosage*
  • Protein Kinase Inhibitors / adverse effects
  • Skin Neoplasms / pathology
  • Troponin I / blood
  • Vemurafenib / administration & dosage*
  • Vemurafenib / adverse effects
  • Ventricular Dysfunction, Left / diagnostic imaging
  • Withholding Treatment

Substances

  • Protein Kinase Inhibitors
  • Troponin I
  • Natriuretic Peptide, Brain
  • Vemurafenib